Research on the Clinical Value of ncRNA in Diabetes and Its Complications

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500110377

Enrollment

Unknown

Registered

2025-10-13

Start date

2025-01-06

Completion date

Unknown

Last updated

2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes and its complications

Interventions

Diabetes with retinopathy group (DR group):NA

Diabetes without retinopathy group (NDR group):NA

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patients with diabetes who have been diagnosed in our hospital; 2. Age >= 18 years old.

Exclusion criteria

Exclusion criteria: 1. Combining diabetic ketoacidosis, diabetic hyperosmolar coma and other acute complications of diabetes; 2. Recent (within the past 3 months) occurrence of cardiovascular or cerebrovascular events; 3. Recent (within the past 3 months) presence of stress conditions (such as acute or chronic infections, trauma, surgery, burns, etc.); 4. Merging tumors; 5. Merge with autoimmune diseases such as psoriasis, systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome; 6. Pregnant or lactating women; 7. Incomplete clinical data.

Design outcomes

Primary

Measure	Time frame
lncRNA;kidney function ;miRNA;	—

Secondary

Measure	Time frame
blood glucose;ico;blood fat;Blood routine test;glycosylated hemoglobin;liver function test;	—

Countries

China

Contacts

Public ContactLi Zimeng

China-Japan Union Hospital of Jilin University

lizimeng19@jlu.edu.cn+86 150 4403 1212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026